GBA1 and Parkinson disease: Drugs such as GZ/SAR402671 (ClinicalTrials.gov Identifier: NCT02906020) and Ambroxol (ClinicalTrials.gov Identifier: NCT02941822 and NCT02914366) have been promoted for randomized interventional trials in PD patients with GBA1 variants.